Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques

Gupta, P.; Sharma, U.; Gupta, P.; Siripurapu, K.B.; Maurya, R. Evolvosides C–E, flavonol-4′-O-triglycosides from evolvulus alsinoides and their anti-stress activity [corrected Bioorg. Med. Chem., 2013, 21(5), 1116-1122.
[http://dx.doi.org/10.1016/j.bmc.2012.12.040] [PMID: 23357036]

Ali, I.; Wani, W.A.; Saleem, K.; Hseih, M-F. Design and synthesis of thalidomide based dithiocarbamate Cu (II), Ni (II) and Ru (III) complexes as anticancer agents. Polyhedron, 2013, 56, 134-143.
[http://dx.doi.org/10.1016/j.poly.2013.03.056]

Ali, I.; Lone, M.N.; Al-Othman, Z.A.; Al-Warthan, A.; Sanagi, M.M. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development. Curr. Drug Targets, 2015, 16(7), 711-734.
[http://dx.doi.org/10.2174/1389450116666150309115922] [PMID: 25751009]

Ali, I. Nano anti-cancer drugs: pros and cons and future perspectives. Curr. Cancer Drug Targets, 2011, 11(2), 131-134.
[http://dx.doi.org/10.2174/156800911794328457] [PMID: 21062238]

Ali, I.; Aboul-Enein, H.Y.; Ghanem, A. Enantioselective toxicity and carcinogenesis. Curr. Pharm. Anal., 2005, 1(1), 109-125.
[http://dx.doi.org/10.2174/1573412052953328]

Ali, I.; Saleem, K.; Wesselinova, D.; Haque, A. Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium (III) complexes. Med. Chem. Res., 2013, 22(3), 1386-1398.
[http://dx.doi.org/10.1007/s00044-012-0133-8]

Ali, I.; Saleem, K.; Aboul-Enein, H.Y.; Rather, A. Social Aspects of Cancer Genesis. Cancer Ther., 2011, 8.

Kishwar, S.; Waseem, L.M. H. Ming, J. Mohamad, Imran, A. Future Med. Chem., 2013, 5(2), 135-146.
[PMID: 23360139]

Ali, I.; Wani, W.A.; Saleem, K.; Wesselinova, D. Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med. Chem., 2013, 9(1), 11-21.
[http://dx.doi.org/10.2174/157340613804488297] [PMID: 22741786]

Ali, I.; Saleem, K.; Uddin, R.; Haque, A.; El-Azzouny, A. Natural products: human friendly anti-cancer medications. Egypt Pharm J, 2010, 9(2), 133-179.

Ali, I.; Wani, W.A.; Haque, A.; Saleem, K. Glutamic acid and its derivatives: candidates for rational design of anticancer drugs. Future Med. Chem., 2013, 5(8), 961-978.
[http://dx.doi.org/10.4155/fmc.13.62] [PMID: 23682571]

Ali, I.; Wani, W.A.; Saleem, K.; Hsieh, M-F. Anticancer metallodrugs of glutamic acid sulphonamides: in silico, DNA binding, hemolysis and anticancer studies. RSC Advances, 2014, 4(56), 29629-29641.
[http://dx.doi.org/10.1039/C4RA02570A]

Ali, I.; Haque, A.; Wani, W.A.; Saleem, K.; Al Za’abi, M. Analyses of anticancer drugs by capillary electrophoresis: a review. Biomed. Chromatogr., 2013, 27(10), 1296-1311.
[http://dx.doi.org/10.1002/bmc.2953] [PMID: 23843248]

Ali, I.; Lone, M.N.; Suhail, M.; Mukhtar, S.D.; Asnin, L. Danish Mukhtar S, Asnin L: Advances in nanocarriers for anticancer drugs delivery. Curr. Med. Chem., 2016, 23(20), 2159-2187.
[http://dx.doi.org/10.2174/0929867323666160405111152] [PMID: 27048343]

Ali, I. Nano drugs: novel agents for cancer chemo-therapy. Curr. Cancer Drug Targets, 2011, 11(2), 130-130.
[http://dx.doi.org/10.2174/156800911794328466] [PMID: 21247391]

Ali, I.; Rahis-Uddin, ; Salim, K.; Rather, M.A.; Wani, W.A.; Haque, A. Advances in nano drugs for cancer chemotherapy. Curr. Cancer Drug Targets, 2011, 11(2), 135-146.
[http://dx.doi.org/10.2174/156800911794328493] [PMID: 21158724]

GBD 2017 Colorectal Cancer Collaborators. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol., 2019, 4(12), 913-933.
[http://dx.doi.org/10.1016/S2468-1253(19)30345-0] [PMID: 31648977]

Fitzmaurice, C.; Abate, D.; Abbasi, N.; Abbastabar, H.; Abd-Allah, F.; Abdel-Rahman, O.; Abdelalim, A.; Abdoli, A.; Abdollahpour, I.; Abdulle, A.S.M.; Abebe, N.D.; Abraha, H.N.; Abu-Raddad, L.J.; Abualhasan, A.; Adedeji, I.A.; Advani, S.M.; Afarideh, M.; Afshari, M.; Aghaali, M.; Agius, D.; Agrawal, S.; Ahmadi, A.; Ahmadian, E.; Ahmadpour, E.; Ahmed, M.B.; Akbari, M.E.; Akinyemiju, T.; Al-Aly, Z.; AlAbdulKader, A.M.; Alahdab, F.; Alam, T.; Alamene, G.M.; Alemnew, B.T.T.; Alene, K.A.; Alinia, C.; Alipour, V.; Aljunid, S.M.; Bakeshei, F.A.; Almadi, M.A.H.; Almasi-Hashiani, A.; Alsharif, U.; Alsowaidi, S.; Alvis-Guzman, N.; Amini, E.; Amini, S.; Amoako, Y.A.; Anbari, Z.; Anber, N.H.; Andrei, C.L.; Anjomshoa, M.; Ansari, F.; Ansariadi, A.; Appiah, S.C.Y.; Arab-Zozani, M.; Arabloo, J.; Arefi, Z.; Aremu, O.; Areri, H.A.; Artaman, A.; Asayesh, H.; Asfaw, E.T.; Ashagre, A.F.; Assadi, R.; Ataeinia, B.; Atalay, H.T.; Ataro, Z.; Atique, S.; Ausloos, M.; Avila-Burgos, L.; Avokpaho, E.F.G.A.; Awasthi, A.; Awoke, N.; Ayala Quintanilla, B.P.; Ayanore, M.A.; Ayele, H.T.; Babaee, E.; Bacha, U.; Badawi, A.; Bagherzadeh, M.; Bagli, E.; Balakrishnan, S.; Balouchi, A.; Bärnighausen, T.W.; Battista, R.J.; Behzadifar, M.; Behzadifar, M.; Bekele, B.B.; Belay, Y.B.; Belayneh, Y.M.; Berfield, K.K.S.; Berhane, A.; Bernabe, E.; Beuran, M.; Bhakta, N.; Bhattacharyya, K.; Biadgo, B.; Bijani, A.; Bin Sayeed, M.S.; Birungi, C.; Bisignano, C.; Bitew, H.; Bjørge, T.; Bleyer, A.; Bogale, K.A.; Bojia, H.A.; Borzì, A.M.; Bosetti, C.; Bou-Orm, I.R.; Brenner, H.; Brewer, J.D.; Briko, A.N.; Briko, N.I.; Bustamante-Teixeira, M.T.; Butt, Z.A.; Carreras, G.; Carrero, J.J.; Carvalho, F.; Castro, C.; Castro, F.; Catalá-López, F.; Cerin, E.; Chaiah, Y.; Chanie, W.F.; Chattu, V.K.; Chaturvedi, P.; Chauhan, N.S.; Chehrazi, M.; Chiang, P.P.; Chichiabellu, T.Y.; Chido-Amajuoyi, O.G.; Chimed-Ochir, O.; Choi, J.J.; Christopher, D.J.; Chu, D.T.; Constantin, M.M.; Costa, V.M.; Crocetti, E.; Crowe, C.S.; Curado, M.P.; Dahlawi, S.M.A.; Damiani, G.; Darwish, A.H.; Daryani, A.; das Neves, J.; Demeke, F.M.; Demis, A.B.; Demissie, B.W.; Demoz, G.T.; Denova-Gutiérrez, E.; Derakhshani, A.; Deribe, K.S.; Desai, R.; Desalegn, B.B.; Desta, M.; Dey, S.; Dharmaratne, S.D.; Dhimal, M.; Diaz, D.; Dinberu, M.T.T.; Djalalinia, S.; Doku, D.T.; Drake, T.M.; Dubey, M.; Dubljanin, E.; Duken, E.E.; Ebrahimi, H.; Effiong, A.; Eftekhari, A.; El Sayed, I.; Zaki, M.E.S.; El-Jaafary, S.I.; El-Khatib, Z.; Elemineh, D.A.; Elkout, H.; Ellenbogen, R.G.; Elsharkawy, A.; Emamian, M.H.; Endalew, D.A.; Endries, A.Y.; Eshrati, B.; Fadhil, I.; Fallah, V.; Faramarzi, M.; Farhangi, M.A.; Farioli, A.; Farzadfar, F.; Fentahun, N.; Fernandes, E.; Feyissa, G.T.; Filip, I.; Fischer, F.; Fisher, J.L.; Force, L.M.; Foroutan, M.; Freitas, M.; Fukumoto, T.; Futran, N.D.; Gallus, S.; Gankpe, F.G.; Gayesa, R.T.; Gebrehiwot, T.T.; Gebremeskel, G.G.; Gedefaw, G.A.; Gelaw, B.K.; Geta, B.; Getachew, S.; Gezae, K.E.; Ghafourifard, M.; Ghajar, A.; Ghashghaee, A.; Gholamian, A.; Gill, P.S.; Ginindza, T.T.G.; Girmay, A.; Gizaw, M.; Gomez, R.S.; Gopalani, S.V.; Gorini, G.; Goulart, B.N.G.; Grada, A.; Ribeiro Guerra, M.; Guimaraes, A.L.S.; Gupta, P.C.; Gupta, R.; Hadkhale, K.; Haj-Mirzaian, A.; Haj-Mirzaian, A.; Hamadeh, R.R.; Hamidi, S.; Hanfore, L.K.; Haro, J.M.; Hasankhani, M.; Hasanzadeh, A.; Hassen, H.Y.; Hay, R.J.; Hay, S.I.; Henok, A.; Henry, N.J.; Herteliu, C.; Hidru, H.D.; Hoang, C.L.; Hole, M.K.; Hoogar, P.; Horita, N.; Hosgood, H.D.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Hussen, M.M.; Ileanu, B.; Ilic, M.D.; Innos, K.; Irvani, S.S.N.; Iseh, K.R.; Islam, S.M.S.; Islami, F.; Jafari Balalami, N.; Jafarinia, M.; Jahangiry, L.; Jahani, M.A.; Jahanmehr, N.; Jakovljevic, M.; James, S.L.; Javanbakht, M.; Jayaraman, S.; Jee, S.H.; Jenabi, E.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joo, T.; Jungari, S.B.; Jürisson, M.; Kabir, A.; Kamangar, F.; Karch, A.; Karimi, N.; Karimian, A.; Kasaeian, A.; Kasahun, G.G.; Kassa, B.; Kassa, T.D.; Kassaw, M.W.; Kaul, A.; Keiyoro, P.N.; Kelbore, A.G.; Kerbo, A.A.; Khader, Y.S.; Khalilarjmandi, M.; Khan, E.A.; Khan, G.; Khang, Y.H.; Khatab, K.; Khater, A.; Khayamzadeh, M.; Khazaee-Pool, M.; Khazaei, S.; Khoja, A.T.; Khosravi, M.H.; Khubchandani, J.; Kianipour, N.; Kim, D.; Kim, Y.J.; Kisa, A.; Kisa, S.; Kissimova-Skarbek, K.; Komaki, H.; Koyanagi, A.; Krohn, K.J.; Bicer, B.K.; Kugbey, N.; Kumar, V.; Kuupiel, D.; La Vecchia, C.; Lad, D.P.; Lake, E.A.; Lakew, A.M.; Lal, D.K.; Lami, F.H.; Lan, Q.; Lasrado, S.; Lauriola, P.; Lazarus, J.V.; Leigh, J.; Leshargie, C.T.; Liao, Y.; Limenih, M.A.; Listl, S.; Lopez, A.D.; Lopukhov, P.D.; Lunevicius, R.; Madadin, M.; Magdeldin, S.; El Razek, H.M.A.; Majeed, A.; Maleki, A.; Malekzadeh, R.; Manafi, A.; Manafi, N.; Manamo, W.A.; Mansourian, M.; Mansournia, M.A.; Mantovani, L.G.; Maroufizadeh, S.; Martini, S.M.S.; Mashamba-Thompson, T.P.; Massenburg, B.B.; Maswabi, M.T.; Mathur, M.R.; McAlinden, C.; McKee, M.; Meheretu, H.A.A.; Mehrotra, R.; Mehta, V.; Meier, T.; Melaku, Y.A.; Meles, G.G.; Meles, H.G.; Melese, A.; Melku, M.; Memiah, P.T.N.; Mendoza, W.; Menezes, R.G.; Merat, S.; Meretoja, T.J.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Mihretie, K.M.M.; Miller, T.R.; Mills, E.J.; Mir, S.M.; Mirzaei, H.; Mirzaei, H.R.; Mishra, R.; Moazen, B.; Mohammad, D.K.; Mohammad, K.A.; Mohammad, Y.; Darwesh, A.M.; Mohammadbeigi, A.; Mohammadi, H.; Mohammadi, M.; Mohammadian, M.; Mohammadian-Hafshejani, A.; Mohammadoo-Khorasani, M.; Mohammadpourhodki, R.; Mohammed, A.S.; Mohammed, J.A.; Mohammed, S.; Mohebi, F.; Mokdad, A.H.; Monasta, L.; Moodley, Y.; Moosazadeh, M.; Moossavi, M.; Moradi, G.; Moradi-Joo, M.; Moradi-Lakeh, M.; Moradpour, F.; Morawska, L.; Morgado-da-Costa, J.; Morisaki, N.; Morrison, S.D.; Mosapour, A.; Mousavi, S.M.; Muche, A.A.; Muhammed, O.S.S.; Musa, J.; Nabhan, A.R.; Naderi, M.; Nagarajan, A.J.; Nagel, G.; Nahvijou, A.; Naik, G.; Najafi, F.; Naldi, L.; Nam, H.S.; Nasiri, N.; Nazari, J.; Negoi, I.; Neupane, S.; Newcomb, P.A.; Nggada, H.A.; Ngunjiri, J.W.; Nguyen, C.T.; Nikniaz, L.; Ningrum, D.N.A.; Nirayo, Y.L.; Nixon, M.R.; Nnaji, C.A.; Nojomi, M.; Nosratnejad, S.; Shiadeh, M.N.; Obsa, M.S.; Ofori-Asenso, R.; Ogbo, F.A.; Oh, I.H.; Olagunju, A.T.; Olagunju, T.O.; Oluwasanu, M.M.; Omonisi, A.E.; Onwujekwe, O.E.; Oommen, A.M.; Oren, E.; Ortega-Altamirano, D.D.V.; Ota, E.; Otstavnov, S.S.; Owolabi, M.O.; P A, M.; Padubidri, J.R.; Pakhale, S.; Pakpour, A.H.; Pana, A.; Park, E.K.; Parsian, H.; Pashaei, T.; Patel, S.; Patil, S.T.; Pennini, A.; Pereira, D.M.; Piccinelli, C.; Pillay, J.D.; Pirestani, M.; Pishgar, F.; Postma, M.J.; Pourjafar, H.; Pourmalek, F.; Pourshams, A.; Prakash, S.; Prasad, N.; Qorbani, M.; Rabiee, M.; Rabiee, N.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi, M.; Rahman, M.A.; Rajati, F.; Rana, S.M.; Raoofi, S.; Rath, G.K.; Rawaf, D.L.; Rawaf, S.; Reiner, R.C.; Renzaho, A.M.N.; Rezaei, N.; Rezapour, A.; Ribeiro, A.I.; Ribeiro, D.; Ronfani, L.; Roro, E.M.; Roshandel, G.; Rostami, A.; Saad, R.S.; Sabbagh, P.; Sabour, S.; Saddik, B.; Safiri, S.; Sahebkar, A.; Salahshoor, M.R.; Salehi, F.; Salem, H.; Salem, M.R.; Salimzadeh, H.; Salomon, J.A.; Samy, A.M.; Sanabria, J.; Santric Milicevic, M.M.; Sartorius, B.; Sarveazad, A.; Sathian, B.; Satpathy, M.; Savic, M.; Sawhney, M.; Sayyah, M.; Schneider, I.J.C.; Schöttker, B.; Sekerija, M.; Sepanlou, S.G.; Sepehrimanesh, M.; Seyedmousavi, S.; Shaahmadi, F.; Shabaninejad, H.; Shahbaz, M.; Shaikh, M.A.; Shamshirian, A.; Shamsizadeh, M.; Sharafi, H.; Sharafi, Z.; Sharif, M.; Sharifi, A.; Sharifi, H.; Sharma, R.; Sheikh, A.; Shirkoohi, R.; Shukla, S.R.; Si, S.; Siabani, S.; Silva, D.A.S.; Silveira, D.G.A.; Singh, A.; Singh, J.A.; Sisay, S.; Sitas, F.; Sobngwi, E.; Soofi, M.; Soriano, J.B.; Stathopoulou, V.; Sufiyan, M.B.; Tabarés-Seisdedos, R.; Tabuchi, T.; Takahashi, K.; Tamtaji, O.R.; Tarawneh, M.R.; Tassew, S.G.; Taymoori, P.; Tehrani-Banihashemi, A.; Temsah, M.H.; Temsah, O.; Tesfay, B.E.; Tesfay, F.H.; Teshale, M.Y.; Tessema, G.A.; Thapa, S.; Tlaye, K.G.; Topor-Madry, R.; Tovani-Palone, M.R.; Traini, E.; Tran, B.X.; Tran, K.B.; Tsadik, A.G.; Ullah, I.; Uthman, O.A.; Vacante, M.; Vaezi, M.; Varona Pérez, P.; Veisani, Y.; Vidale, S.; Violante, F.S.; Vlassov, V.; Vollset, S.E.; Vos, T.; Vosoughi, K.; Vu, G.T.; Vujcic, I.S.; Wabinga, H.; Wachamo, T.M.; Wagnew, F.S.; Waheed, Y.; Weldegebreal, F.; Weldesamuel, G.T.; Wijeratne, T.; Wondafrash, D.Z.; Wonde, T.E.; Wondmieneh, A.B.; Workie, H.M.; Yadav, R.; Yadegar, A.; Yadollahpour, A.; Yaseri, M.; Yazdi-Feyzabadi, V.; Yeshaneh, A.; Yimam, M.A.; Yimer, E.M.; Yisma, E.; Yonemoto, N.; Younis, M.Z.; Yousefi, B.; Yousefifard, M.; Yu, C.; Zabeh, E.; Zadnik, V.; Moghadam, T.Z.; Zaidi, Z.; Zamani, M.; Zandian, H.; Zangeneh, A.; Zaki, L.; Zendehdel, K.; Zenebe, Z.M.; Zewale, T.A.; Ziapour, A.; Zodpey, S.; Murray, C.J.L. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol., 2019, 5(12), 1749-1768.
[http://dx.doi.org/10.1001/jamaoncol.2019.2996] [PMID: 31560378]

Ghasemi, F.; Shafiee, M.; Banikazemi, Z.; Pourhanifeh, M.H.; Khanbabaei, H.; Shamshirian, A.; Amiri Moghadam, S.; ArefNezhad, R.; Sahebkar, A.; Avan, A.; Mirzaei, H. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol. Res. Pract., 2019, 215(10)152556
[http://dx.doi.org/10.1016/j.prp.2019.152556] [PMID: 31358480]

Nahand, J.S.; Taghizadeh-Boroujeni, S.; Karimzadeh, M.; Borran, S.; Pourhanifeh, M.H.; Moghoofei, M.; Bokharaei-Salim, F.; Karampoor, S.; Jafari, A.; Asemi, Z.; Tbibzadeh, A.; Namdar, A.; Mirzaei, H. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. J. Cell. Physiol., 2019, 234(10), 17064-17099.
[http://dx.doi.org/10.1002/jcp.28457] [PMID: 30891784]

Shafabakhsh, R.; Reiter, R.J.; Mirzaei, H.; Teymoordash, S.N.; Asemi, Z. Melatonin: A new inhibitor agent for cervical cancer treatment. J. Cell. Physiol., 2019, 234(12), 21670-21682.
[http://dx.doi.org/10.1002/jcp.28865] [PMID: 31131897]

Shrestha, A.D.; Neupane, D.; Vedsted, P.; Kallestrup, P. Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review. Asian Pac. J. Cancer Prev., 2018, 19(2), 319-324.
[PMID: 29479954]

Rabelo-Santos, S.H.; Termini, L.; Boccardo, E.; Derchain, S.; Longatto-Filho, A.; Andreoli, M.A.; Costa, M.C.; Lima Nunes, R.A.; Lucci Ângelo-Andrade, L.A.; Villa, L.L.; Zeferino, L.C. Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. Oncotarget, 2018, 9(31), 21630-21640.
[http://dx.doi.org/10.18632/oncotarget.24850] [PMID: 29774090]

Yost, S.; Hoekstra, A. Cervical cancer in women over 65: An analysis of screening. Gynecol. Oncol. Rep., 2018, 25, 48-51.
[http://dx.doi.org/10.1016/j.gore.2018.05.010] [PMID: 30023421]

Swanson, M.; Ibrahim, S.; Blat, C.; Oketch, S.; Olwanda, E.; Maloba, M.; Huchko, M.J. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. BMC Womens Health, 2018, 18(1), 116.
[http://dx.doi.org/10.1186/s12905-018-0586-0] [PMID: 29970063]

Gupta, R.; Gupta, S.; Mehrotra, R.; Sodhani, P. Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions. Asian Pac. J. Cancer Prev., 2017, 18(6), 1461-1467.
[PMID: 28669152]

Davoodvandi, A.; Sahebnasagh, R.; Mardanshah, O.; Asemi, Z.; Nejati, M.; Shahrzad, M.K.; Mirzaei, H.R.; Mirzaei, H. Medicinal Plants As Natural Polarizers of Macrophages: Phytochemicals and Pharmacological Effects. Curr. Pharm. Des., 2019, 25(30), 3225-3238.
[http://dx.doi.org/10.2174/1381612825666190829154934] [PMID: 31465276]

Faghihloo, E.; Araei, Y.; Mohammadi, M.; Mirzaei, H.; Mohammadi, H.R.; Mokhtari-Azad, T. The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line. Cancer Gene Ther., 2016, 23(11), 396-399.
[http://dx.doi.org/10.1038/cgt.2016.52] [PMID: 27767089]

Hashemi Goradel, N.; Ghiyami-Hour, F.; Jahangiri, S.; Negahdari, B.; Sahebkar, A.; Masoudifar, A.; Mirzaei, H. Nanoparticles as new tools for inhibition of cancer angiogenesis. J. Cell. Physiol., 2018, 233(4), 2902-2910.
[http://dx.doi.org/10.1002/jcp.26029] [PMID: 28543172]

Hesari, A.; Azizian, M.; Sheikhi, A.; Nesaei, A.; Sanaei, S.; Mahinparvar, N.; Derakhshani, M.; Hedayt, P.; Ghasemi, F.; Mirzaei, H. Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status. Int. J. Cancer, 2019, 144(6), 1215-1226.
[http://dx.doi.org/10.1002/ijc.31947] [PMID: 30362511]

Honari, M.; Shafabakhsh, R.; Reiter, R.J.; Mirzaei, H.; Asemi, Z. Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms. Cancer Cell Int., 2019, 19, 180.
[http://dx.doi.org/10.1186/s12935-019-0906-y] [PMID: 31341423]

Mashreghi, M.; Azarpara, H.; Bazaz, M.R.; Jafari, A.; Masoudifar, A.; Mirzaei, H.; Jaafari, M.R. Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. J. Cell. Physiol., 2018, 233(4), 2949-2965.
[http://dx.doi.org/10.1002/jcp.26049] [PMID: 28608549]

Mirzaei, H.; Khoi, M.J.; Azizi, M.; Goodarzi, M. Can curcumin and its analogs be a new treatment option in cancer therapy? Cancer Gene Ther., 2016, 23(11), 410.
[http://dx.doi.org/10.1038/cgt.2016.47] [PMID: 27853147]

Mirzaei, H.; Naseri, G.; Rezaee, R.; Mohammadi, M.; Banikazemi, Z.; Mirzaei, H.R.; Salehi, H.; Peyvandi, M.; Pawelek, J.M.; Sahebkar, A. Curcumin: A new candidate for melanoma therapy? Int. J. Cancer, 2016, 139(8), 1683-1695.
[http://dx.doi.org/10.1002/ijc.30224] [PMID: 27280688]

Mirzaei, H.; Sahebkar, A.; Avan, A.; Jaafari, M.R.; Salehi, R.; Salehi, H.; Baharvand, H.; Rezaei, A.; Hadjati, J.; Pawelek, J.M.; Mirzaei, H.R. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents. Curr. Med. Chem., 2016, 23(5), 455-463.
[http://dx.doi.org/10.2174/0929867323666151217122033] [PMID: 26674785]

Mirzaei, H.; Sahebkar, A.; Jaafari, M.R.; Hadjati, J.; Javanmard, S.H.; Mirzaei, H.R.; Salehi, R. PiggyBac as a novel vector in cancer gene therapy: current perspective. Cancer Gene Ther., 2016, 23(2-3), 45-47.
[http://dx.doi.org/10.1038/cgt.2015.68] [PMID: 26742580]

Mirzaei, H.; Sahebkar, A.; Sichani, L.S.; Moridikia, A.; Nazari, S.; Sadri Nahand, J.; Salehi, H.; Stenvang, J.; Masoudifar, A.; Mirzaei, H.R.; Jaafari, M.R. Therapeutic application of multipotent stem cells. J. Cell. Physiol., 2018, 233(4), 2815-2823.
[http://dx.doi.org/10.1002/jcp.25990] [PMID: 28475219]

Mirzaei, H.; Salehi, H.; Oskuee, R.K.; Mohammadpour, A.; Mirzaei, H.R.; Sharifi, M.R.; Salarinia, R.; Darani, H.Y.; Mokhtari, M.; Masoudifar, A.; Sahebkar, A.; Salehi, R.; Jaafari, M.R. The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Cancer Lett., 2018, 419, 30-39.
[http://dx.doi.org/10.1016/j.canlet.2018.01.029] [PMID: 29331419]

Mirzaei, H.; Shakeri, A.; Rashidi, B.; Jalili, A.; Banikazemi, Z.; Sahebkar, A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed. Pharmacother., 2017, 85, 102-112.
[http://dx.doi.org/10.1016/j.biopha.2016.11.098] [PMID: 27930973]

Mirzaei, H.; Yazdi, F.; Salehi, R.; Mirzaei, H.R. SiRNA and epigenetic aberrations in ovarian cancer. J. Cancer Res. Ther., 2016, 12(2), 498-508.
[http://dx.doi.org/10.4103/0973-1482.153661] [PMID: 27461600]

Mirzaei, H.R.; Jamali, A.; Jafarzadeh, L.; Masoumi, E.; Alishah, K.; Fallah Mehrjardi, K.; Emami, S.A.H.; Noorbakhsh, F.; Till, B.G.; Hadjati, J. Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells. J. Cell. Physiol., 2019, 234(6), 9207-9215.
[http://dx.doi.org/10.1002/jcp.27599] [PMID: 30362586]

Mirzaei, H.R.; Mirzaei, H.; Lee, S.Y.; Hadjati, J.; Till, B.G. Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy. Cancer Lett., 2016, 380(2), 413-423.
[http://dx.doi.org/10.1016/j.canlet.2016.07.001] [PMID: 27392648]

Mirzaei, H.R.; Pourghadamyari, H.; Rahmati, M.; Mohammadi, A.; Nahand, J.S.; Rezaei, A.; Mirzaei, H.; Hadjati, J. Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy. Cancer Lett., 2018, 423, 95-104.
[http://dx.doi.org/10.1016/j.canlet.2018.03.010] [PMID: 29544719]

Mirzaei, H.R.; Rodriguez, A.; Shepphird, J.; Brown, C.E.; Badie, B. Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. Front. Immunol., 2017, 8, 1850.
[http://dx.doi.org/10.3389/fimmu.2017.01850] [PMID: 29312333]

Mirzaei, H.R.; Sahebkar, A.; Salehi, R.; Nahand, J.S.; Karimi, E.; Jaafari, M.R.; Mirzaei, H. Boron neutron capture therapy: Moving toward targeted cancer therapy. J. Cancer Res. Ther., 2016, 12(2), 520-525.
[http://dx.doi.org/10.4103/0973-1482.176167] [PMID: 27461603]

Mohammadi, M.; Jaafari, M.R.; Mirzaei, H.R.; Mirzaei, H. Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Ther., 2016, 23(9), 285-286.
[http://dx.doi.org/10.1038/cgt.2016.35] [PMID: 27650780]

Moradian Tehrani, R.; Verdi, J.; Noureddini, M.; Salehi, R.; Salarinia, R.; Mosalaei, M.; Simonian, M.; Alani, B.; Ghiasi, M.R.; Jaafari, M.R.; Mirzaei, H.R.; Mirzaei, H. Mesenchymal stem cells: A new platform for targeting suicide genes in cancer. J. Cell. Physiol., 2018, 233(5), 3831-3845.
[http://dx.doi.org/10.1002/jcp.26094] [PMID: 28703313]

Pourhanifeh, M.H.; Mohammadi, R.; Noruzi, S.; Hosseini, S.A.; Fanoudi, S.; Mohamadi, Y.; Hashemzehi, M.; Asemi, Z.; Mirzaei, H.R.; Salarinia, R.; Mirzaei, H. The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int., 2019, 19, 157.
[http://dx.doi.org/10.1186/s12935-019-0870-6] [PMID: 31198406]

Rashidi, B; Malekzadeh, M; Goodarzi, M; Masoudifar, A; Mirzaei, H Green tea and its anti-angiogenesis effects. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie , 2017, 89, 949-956.
[http://dx.doi.org/10.1016/j.biopha.2017.01.161]

Sadeghi, S.; Davoodvandi, A.; Pourhanifeh, M.H.; Sharifi, N.; ArefNezhad, R.; Sahebnasagh, R.; Moghadam, S.A.; Sahebkar, A.; Mirzaei, H. Anti-cancer effects of cinnamon: Insights into its apoptosis effects. Eur. J. Med. Chem., 2019, 178, 131-140.
[http://dx.doi.org/10.1016/j.ejmech.2019.05.067] [PMID: 31195168]

Tamtaji, O.R.; Mirzaei, H.; Shamshirian, A.; Shamshirian, D.; Behnam, M.; Asemi, Z. New trends in glioma cancer therapy: Targeting Na⁺/H ⁺ exchangers. J. Cell. Physiol., 2020, 235(2), 658-665.
[http://dx.doi.org/10.1002/jcp.29014] [PMID: 31250444]

Vakili-Ghartavol, R.; Mombeiny, R.; Salmaninejad, A.; Sorkhabadi, S.M.R.; Faridi-Majidi, R.; Jaafari, M.R.; Mirzaei, H. Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view. J. Cell. Physiol., 2018, 233(12), 9223-9236.
[http://dx.doi.org/10.1002/jcp.27027] [PMID: 30078227]

Shafabakhsh, R.; Pourhanifeh, M.H.; Mirzaei, H.R.; Sahebkar, A.; Asemi, Z.; Mirzaei, H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol. Res., 2019, 147104353
[http://dx.doi.org/10.1016/j.phrs.2019.104353] [PMID: 31306775]

Khan, H.; Mirzaei, H.R.; Amiri, A.; Kupeli Akkol, E.; Ashhad Halimi, S.M.; Mirzaei, H. Glyco-nanoparticles: New drug delivery systems in cancer therapy. Semin. Cancer Biol., 2019.S1044-579X(19)30400-6
[http://dx.doi.org/10.1016/j.semcancer.2019.12.004] [PMID: 31870939]

Salehi, M; Movahedpour, A; Tayarani, A; Shabaninejad, Z; Pourhanifeh, MH; Mortezapour, E; Nickdasti, A; Mottaghi, R; Davoodabadi, A; Khan, H Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma., 2020.
[http://dx.doi.org/10.1002/ptr.6704]

Alirezaei, Z.; Pourhanifeh, M.H.; Borran, S.; Nejati, M.; Mirzaei, H.; Hamblin, M.R. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders. Mol. Neurobiol., 2020, 57(1), 469-491.
[http://dx.doi.org/10.1007/s12035-019-01698-3] [PMID: 31385229]

Jafari, S.H.; Saadatpour, Z.; Salmaninejad, A.; Momeni, F.; Mokhtari, M.; Nahand, J.S.; Rahmati, M.; Mirzaei, H.; Kianmehr, M. Breast cancer diagnosis: Imaging techniques and biochemical markers. J. Cell. Physiol., 2018, 233(7), 5200-5213.
[http://dx.doi.org/10.1002/jcp.26379] [PMID: 29219189]

Keshavarzi, M.; Darijani, M.; Momeni, F.; Moradi, P.; Ebrahimnejad, H.; Masoudifar, A.; Mirzaei, H. Molecular Imaging and Oral Cancer Diagnosis and Therapy. J. Cell. Biochem., 2017, 118(10), 3055-3060.
[http://dx.doi.org/10.1002/jcb.26042] [PMID: 28390191]

Keshavarzi, M.; Sorayayi, S.; Jafar Rezaei, M.; Mohammadi, M.; Ghaderi, A.; Rostamzadeh, A.; Masoudifar, A.; Mirzaei, H. MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy. J. Cell. Biochem., 2017, 118(12), 4121-4128.
[http://dx.doi.org/10.1002/jcb.26012] [PMID: 28370207]

Mirzaei, H.R.; Mirzaei, H.; Namdar, A.; Rahmati, M.; Till, B.G.; Hadjati, J. Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective. J. Cell. Physiol., 2019, 234(5), 5827-5841.
[http://dx.doi.org/10.1002/jcp.27519] [PMID: 30317583]

Momeni, F.; Ghaemmaghami, A.B.; Nejati, M.; Pourhanifeh, M.H.; Sichani, L.S.; Tamtaji, O.R.; Momeni, M.; Khosravi, A.; Etemadifar, M.; Mirzaei, H. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis. Curr. Med. Chem., 2019.
[http://dx.doi.org/10.2174/0929867326666191014162713] [PMID: 31633472]

Saadatpour, Z.; Bjorklund, G.; Chirumbolo, S.; Alimohammadi, M.; Ehsani, H.; Ebrahiminejad, H.; Pourghadamyari, H.; Baghaei, B.; Mirzaei, H.R.; Sahebkar, A.; Mirzaei, H.; Keshavarzi, M. Molecular imaging and cancer gene therapy. Cancer Gene Ther., 2016.
[http://dx.doi.org/10.1038/cgt.2016.62] [PMID: 27857058]

Saadatpour, Z.; Rezaei, A.; Ebrahimnejad, H.; Baghaei, B.; Bjorklund, G.; Chartrand, M.; Sahebkar, A.; Morovati, H.; Mirzaei, H.R.; Mirzaei, H. Imaging techniques: new avenues in cancer gene and cell therapy. Cancer Gene Ther., 2017, 24(1), 1-5.
[http://dx.doi.org/10.1038/cgt.2016.61] [PMID: 27834357]

Boone, J.D.; Erickson, B.K.; Huh, W.K. New insights into cervical cancer screening. J. Gynecol. Oncol., 2012, 23(4), 282-287.
[http://dx.doi.org/10.3802/jgo.2012.23.4.282] [PMID: 23094132]

Nanda, K.; McCrory, D.C.; Myers, E.R.; Bastian, L.A.; Hasselblad, V.; Hickey, J.D.; Matchar, D.B. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med., 2000, 132(10), 810-819.
[http://dx.doi.org/10.7326/0003-4819-132-10-200005160-00009] [PMID: 10819705]

Bourgioti, C.; Chatoupis, K.; Moulopoulos, L.A. Current imaging strategies for the evaluation of uterine cervical cancer. World J. Radiol., 2016, 8(4), 342-354.
[http://dx.doi.org/10.4329/wjr.v8.i4.342] [PMID: 27158421]

Patel, S.; Liyanage, S.H.; Sahdev, A.; Rockall, A.G.; Reznek, R.H. Imaging of endometrial and cervical cancer. Insights Imaging, 2010, 1(5-6), 309-328.
[http://dx.doi.org/10.1007/s13244-010-0042-7] [PMID: 22347925]

Kori, M.; Yalcin Arga, K. Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One, 2018, 13(7)e0200717
[http://dx.doi.org/10.1371/journal.pone.0200717] [PMID: 30020984]

Wang, S.; Chen, X. Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis. Oncol. Lett., 2018, 16(4), 5200-5208.
[http://dx.doi.org/10.3892/ol.2018.9323] [PMID: 30250588]

Banikazemi, Z.; Haji, H.A.; Mohammadi, M.; Taheripak, G.; Iranifar, E.; Poursadeghiyan, M.; Moridikia, A.; Rashidi, B.; Taghizadeh, M.; Mirzaei, H. Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes. J. Cell. Biochem., 2018, 119(1), 185-196.
[http://dx.doi.org/10.1002/jcb.26244] [PMID: 28657651]

Mirzaei, H.; Sahebkar, A.; Jaafari, M.R.; Goodarzi, M.; Mirzaei, H.R. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale? J. Cell. Physiol., 2017, 232(12), 3251-3260.
[http://dx.doi.org/10.1002/jcp.25739] [PMID: 27966794]

Mohammadi, S.; Yousefi, F.; Shabaninejad, Z.; Movahedpour, A.; Mahjoubin Tehran, M.; Shafiee, A.; Moradizarmehri, S.; Hajighadimi, S.; Savardashtaki, A.; Mirzaei, H. Exosomes and cancer: From oncogenic roles to therapeutic applications. IUBMB Life, 2020, 72(4), 724-748.
[http://dx.doi.org/10.1002/iub.2182] [PMID: 31618516]

Saadatpour, L.; Fadaee, E.; Fadaei, S.; Nassiri Mansour, R.; Mohammadi, M.; Mousavi, S.M.; Goodarzi, M.; Verdi, J.; Mirzaei, H. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther., 2016, 23(12), 415-418.
[http://dx.doi.org/10.1038/cgt.2016.48] [PMID: 27834360]

Sadri Nahand, J.; Moghoofei, M.; Salmaninejad, A.; Bahmanpour, Z.; Karimzadeh, M.; Nasiri, M.; Mirzaei, H.R.; Pourhanifeh, M.H.; Bokharaei-Salim, F.; Mirzaei, H.; Hamblin, M.R. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review. Int. J. Cancer, 2020, 146(2), 305-320.
[http://dx.doi.org/10.1002/ijc.32688] [PMID: 31566705]

Tavakolizadeh, J.; Roshanaei, K.; Salmaninejad, A.; Yari, R.; Nahand, J.S.; Sarkarizi, H.K.; Mousavi, S.M.; Salarinia, R.; Rahmati, M.; Mousavi, S.F.; Mokhtari, R.; Mirzaei, H. MicroRNAs and exosomes in depression: Potential diagnostic biomarkers. J. Cell. Biochem., 2018, 119(5), 3783-3797.
[http://dx.doi.org/10.1002/jcb.26599] [PMID: 29236313]

Pecorelli, S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet., 2009, 105(2), 103-104.
[http://dx.doi.org/10.1016/j.ijgo.2009.02.012] [PMID: 19367689]

Pecorelli, S.; Zigliani, L.; Odicino, F. Revised FIGO staging for carcinoma of the cervix. Int. J. Gynaecol. Obstet., 2009, 105(2), 107-108.
[http://dx.doi.org/10.1016/j.ijgo.2009.02.009] [PMID: 19342051]

Bhosale, P.; Peungjesada, S.; Devine, C.; Balachandran, A.; Iyer, R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J. Comput. Assist. Tomogr., 2010, 34(6), 855-864.
[http://dx.doi.org/10.1097/RCT.0b013e3181ed3090] [PMID: 21084900]

Mirpour, S.; Mhlanga, J.C.; Logeswaran, P.; Russo, G.; Mercier, G.; Subramaniam, R.M. The role of PET/CT in the management of cervical cancer. AJR Am. J. Roentgenol., 2013, 201(2)W192-205
[http://dx.doi.org/10.2214/AJR.12.9830] [PMID: 23883234]

Grigsby, P.W. The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging, 2008, 8(1), 146-155.
[http://dx.doi.org/10.1102/1470-7330.2008.0022] [PMID: 18694852]

Romesser, P.B.; Qureshi, M.M.; Shah, B.A.; Chatburn, L.T.; Jalisi, S.; Devaiah, A.K.; Subramaniam, R.M.; Truong, M.T. Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy. Ann. Nucl. Med., 2012, 26(7), 527-534.
[http://dx.doi.org/10.1007/s12149-012-0604-5] [PMID: 22610386]

Eschmann, S.M.; Friedel, G.; Paulsen, F.; Reimold, M.; Hehr, T.; Budach, W.; Scheiderbauer, J.; Machulla, H.J.; Dittmann, H.; Vonthein, R.; Bares, R. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur. J. Nucl. Med. Mol. Imaging, 2006, 33(3), 263-269.
[http://dx.doi.org/10.1007/s00259-005-1953-2] [PMID: 16270214]

Kidd, E.A.; Siegel, B.A.; Dehdashti, F.; Grigsby, P.W. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer, 2007, 110(8), 1738-1744.
[http://dx.doi.org/10.1002/cncr.22974] [PMID: 17786947]

Havrilesky, L.J.; Kulasingam, S.L.; Matchar, D.B.; Myers, E.R. FDG-PET for management of cervical and ovarian cancer. Gynecol. Oncol., 2005, 97(1), 183-191.
[http://dx.doi.org/10.1016/j.ygyno.2004.12.007] [PMID: 15790456]

Ryu, SY; Kim, MH; Choi, SC; Choi, CW; Lee, KH Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, 44(3), 347-352.

Son, H.; Kositwattanarerk, A.; Hayes, M.P.; Chuang, L.; Rahaman, J.; Heiba, S.; Machac, J.; Zakashansky, K.; Kostakoglu, L. PET/CT evaluation of cervical cancer: spectrum of disease. Radiographics, 2010, 30(5), 1251-1268.
[http://dx.doi.org/10.1148/rg.305105703] [PMID: 20833849]

deSouza, N.M.; Dina, R.; McIndoe, G.A.; Soutter, W.P. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol. Oncol., 2006, 102(1), 80-85.
[http://dx.doi.org/10.1016/j.ygyno.2005.11.038] [PMID: 16427688]

Sala, E.; Rockall, A.G.; Freeman, S.J.; Mitchell, D.G.; Reinhold, C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology, 2013, 266(3), 717-740.
[http://dx.doi.org/10.1148/radiol.12120315] [PMID: 23431227]

Sala, E.; Wakely, S.; Senior, E.; Lomas, D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am. J. Roentgenol., 2007, 188(6), 1577-1587.
[http://dx.doi.org/10.2214/AJR.06.1196] [PMID: 17515380]

Chung, H.H.; Kang, S.B.; Cho, J.Y.; Kim, J.W.; Park, N.H.; Song, Y.S.; Kim, S.H.; Lee, H.P. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer? Jpn. J. Clin. Oncol., 2007, 37(5), 370-375.
[http://dx.doi.org/10.1093/jjco/hym036] [PMID: 17556538]

Leach, M.O.; Brindle, K.M.; Evelhoch, J.L.; Griffiths, J.R.; Horsman, M.R.; Jackson, A.; Jayson, G.C.; Judson, I.R.; Knopp, M.V.; Maxwell, R.J.; McIntyre, D.; Padhani, A.R.; Price, P.; Rathbone, R.; Rustin, G.J.; Tofts, P.S.; Tozer, G.M.; Vennart, W.; Waterton, J.C.; Williams, S.R.; Workman, P. Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br. J. Cancer, 2005, 92(9), 1599-1610.
[http://dx.doi.org/10.1038/sj.bjc.6602550] [PMID: 15870830]

Funt, S.A.; Hricak, H. Ovarian malignancies. Top. Magn. Reson. Imaging, 2003, 14(4), 329-337.
[http://dx.doi.org/10.1097/00002142-200308000-00005] [PMID: 14578777]

Harry, V.N.; Semple, S.I.; Gilbert, F.J.; Parkin, D.E. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol. Oncol., 2008, 111(2), 213-220.
[http://dx.doi.org/10.1016/j.ygyno.2008.07.048] [PMID: 18774597]

Follen, M.; Levenback, C.F.; Iyer, R.B.; Grigsby, P.W.; Boss, E.A.; Delpassand, E.S.; Fornage, B.D.; Fishman, E.K. Imaging in cervical cancer. Cancer, 2003, 98(9)(Suppl.), 2028-2038.
[http://dx.doi.org/10.1002/cncr.11679] [PMID: 14603539]

Sun, L.T.; Ning, C.P.; Liu, Y.J.; Wang, Z.Z.; Wang, L.D.; Kong, X.C.; Tian, J.W. Is transvaginal elastography useful in pre-operative diagnosis of cervical cancer? Eur. J. Radiol., 2012, 81(8), e888-e892.
[http://dx.doi.org/10.1016/j.ejrad.2012.04.025] [PMID: 22717123]

Fischerova, D; Cibula, D; Stenhova, H; Vondrichova, H; Calda, P; Zikan, M; Freitag, P; Slama, J; Dundr, P; Belacek, J Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2008, 18(4), 766-772.
[http://dx.doi.org/10.1111/j.1525-1438.2007.01072.x]

Unger, J.B.; Ivy, J.J.; Connor, P.; Charrier, A.; Ramaswamy, M.R.; Ampil, F.L.; Monsour, R.P. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol. Oncol., 2004, 94(1), 212-216.
[http://dx.doi.org/10.1016/j.ygyno.2004.04.021] [PMID: 15262145]

Hricak, H.; Gatsonis, C.; Chi, D.S.; Amendola, M.A.; Brandt, K.; Schwartz, L.H.; Koelliker, S.; Siegelman, E.S.; Brown, J.J.; McGhee, R.B., Jr; Iyer, R.; Vitellas, K.M.; Snyder, B.; Long, H.J., III; Fiorica, J.V.; Mitchell, D.G. American College of Radiology Imaging Network 6651; Gynecologic Oncology Group 183. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J. Clin. Oncol., 2005, 23(36), 9329-9337.
[http://dx.doi.org/10.1200/JCO.2005.02.0354] [PMID: 16361632]

Sironi, S.; Buda, A.; Picchio, M.; Perego, P.; Moreni, R.; Pellegrino, A.; Colombo, M.; Mangioni, C.; Messa, C.; Fazio, F. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology, 2006, 238(1), 272-279.
[http://dx.doi.org/10.1148/radiol.2381041799] [PMID: 16304090]

Hricak, H.; Gatsonis, C.; Coakley, F.V.; Snyder, B.; Reinhold, C.; Schwartz, L.H.; Woodward, P.J.; Pannu, H.K.; Amendola, M.; Mitchell, D.G. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology, 2007, 245(2), 491-498.
[http://dx.doi.org/10.1148/radiol.2452061983] [PMID: 17940305]

Shweel, M.A.; Abdel-Gawad, E.A.; Abdel-Gawad, E.A.; Abdelghany, H.S.; Abdel-Rahman, A.M.; Ibrahim, E.M. Uterine cervical malignancy: diagnostic accuracy of MRI with histopathologic correlation. J. Clin. Imaging Sci., 2012, 2, 42.
[http://dx.doi.org/10.4103/2156-7514.99175] [PMID: 22919556]

Grueneisen, J.; Schaarschmidt, B.M.; Heubner, M.; Aktas, B.; Kinner, S.; Forsting, M.; Lauenstein, T.; Ruhlmann, V.; Umutlu, L. Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur. J. Nucl. Med. Mol. Imaging, 2015, 42(12), 1814-1824.
[http://dx.doi.org/10.1007/s00259-015-3131-5] [PMID: 26199113]

Downey, K.; Attygalle, A.D.; Morgan, V.A.; Giles, S.L.; MacDonald, A.; Davis, M.; Ind, T.E.; Shepherd, J.H.; deSouza, N.M. Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur. Radiol., 2016, 26(4), 941-950.
[http://dx.doi.org/10.1007/s00330-015-3899-5] [PMID: 26162579]

Bhosale, P.R.; Iyer, R.B.; Ramalingam, P.; Schmeler, K.M.; Wei, W.; Bassett, R.L.; Ramirez, P.T.; Frumovitz, M. Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2? Clin. Radiol., 2016, 71(6), 515-522.
[http://dx.doi.org/10.1016/j.crad.2016.02.009] [PMID: 27012496]

Jung, W.; Park, K.R.; Lee, K.J.; Kim, K.; Lee, J.; Jeong, S.; Kim, Y.J.; Kim, J.; Yoon, H.J.; Kang, B.C.; Koo, H.S.; Sung, S.H.; Cho, M.S.; Park, S. Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer. Radiat. Oncol. J., 2017, 35(4), 340-348.
[http://dx.doi.org/10.3857/roj.2017.00206] [PMID: 29232805]

Tanaka, T.; Sasaki, S.; Tsuchihashi, H.; Terai, Y.; Yamamoto, K.; Yamada, T.; Ohmichi, M. Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study. Medicine (Baltimore), 2018, 97(16)e0410
[http://dx.doi.org/10.1097/MD.0000000000010410] [PMID: 29668599]

Wentzensen, N.; von Knebel Doeberitz, M. Biomarkers in cervical cancer screening. Dis. Markers, 2007, 23(4), 315-330.
[http://dx.doi.org/10.1155/2007/678793] [PMID: 17627065]

Sahasrabuddhe, V.V.; Luhn, P.; Wentzensen, N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol., 2011, 6(9), 1083-1098.
[http://dx.doi.org/10.2217/fmb.11.87] [PMID: 21958146]

Garland, S.M. Can cervical cancer be eradicated by prophylactic HPV vaccination? Challenges to vaccine implementation. Indian J. Med. Res., 2009, 130(3), 311-321.
[PMID: 19901440]

McGraw, S.L.; Ferrante, J.M. Update on prevention and screening of cervical cancer. World J. Clin. Oncol., 2014, 5(4), 744-752.
[http://dx.doi.org/10.5306/wjco.v5.i4.744] [PMID: 25302174]

Solomon, D.; Davey, D.; Kurman, R.; Moriarty, A.; O’Connor, D.; Prey, M.; Raab, S.; Sherman, M.; Wilbur, D.; Wright, T., Jr; Young, N. Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 2002, 287(16), 2114-2119.
[http://dx.doi.org/10.1001/jama.287.16.2114] [PMID: 11966386]

Rodríguez, A.C.; Schiffman, M.; Herrero, R.; Wacholder, S.; Hildesheim, A.; Castle, P.E.; Solomon, D.; Burk, R. Proyecto Epidemiológico Guanacaste Group. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl. Cancer Inst., 2008, 100(7), 513-517.
[http://dx.doi.org/10.1093/jnci/djn044] [PMID: 18364507]

Wright, T.C., Jr; Schiffman, M.; Solomon, D.; Cox, J.T.; Garcia, F.; Goldie, S.; Hatch, K.; Noller, K.L.; Roach, N.; Runowicz, C.; Saslow, D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol., 2004, 103(2), 304-309.
[http://dx.doi.org/10.1097/01.AOG.0000109426.82624.f8] [PMID: 14754700]

Cuzick, J.; Szarewski, A.; Cubie, H.; Hulman, G.; Kitchener, H.; Luesley, D.; McGoogan, E.; Menon, U.; Terry, G.; Edwards, R.; Brooks, C.; Desai, M.; Gie, C.; Ho, L.; Jacobs, I.; Pickles, C.; Sasieni, P. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet, 2003, 362(9399), 1871-1876.
[http://dx.doi.org/10.1016/S0140-6736(03)14955-0] [PMID: 14667741]

Cuzick, J.; Mayrand, M.H.; Ronco, G.; Snijders, P.; Wardle, J. Chapter 10: New dimensions in cervical cancer screeningVaccine ; , 2006, 3, p. (24 Suppl)S3/90-97.

zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2002, 2(5), 342-350.
[http://dx.doi.org/10.1038/nrc798] [PMID: 12044010]

von Knebel Doeberitz, M New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. European journal of cancer (Oxford, England : 1990), 2002, 38(17), 2229-2242.
[http://dx.doi.org/10.1016/S0959-8049(02)00462-8]

Klaes, R.; Benner, A.; Friedrich, T.; Ridder, R.; Herrington, S.; Jenkins, D.; Kurman, R.J.; Schmidt, D.; Stoler, M.; von Knebel Doeberitz, M. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol., 2002, 26(11), 1389-1399.
[http://dx.doi.org/10.1097/00000478-200211000-00001] [PMID: 12409715]

Wang, S.S.; Trunk, M.; Schiffman, M.; Herrero, R.; Sherman, M.E.; Burk, R.D.; Hildesheim, A.; Bratti, M.C.; Wright, T.; Rodriguez, A.C.; Chen, S.; Reichert, A.; von Knebel Doeberitz, C.; Ridder, R.; von Knebel Doeberitz, M. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol. Biomarkers Prev., 2004, 13(8), 1355-1360.
[PMID: 15298958]

Trunk, M.J.; Dallenbach-Hellweg, G.; Ridder, R.; Petry, K.U.; Ikenberg, H.; Schneider, V.; von Knebel Doeberitz, M. Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples. Acta Cytol., 2004, 48(6), 771-782.
[http://dx.doi.org/10.1159/000326445] [PMID: 15581161]

Wentzensen, N.; Bergeron, C.; Cas, F.; Eschenbach, D.; Vinokurova, S.; von Knebel Doeberitz, M. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer, 2005, 105(6), 461-467.
[http://dx.doi.org/10.1002/cncr.21378] [PMID: 16116604]

Carozzi, F.; Cecchini, S.; Confortini, M.; Becattini, V.; Cariaggi, M.P.; Pontenani, G.; Sani, C.; Ciatto, S. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer, 2006, 108(2), 119-123.
[http://dx.doi.org/10.1002/cncr.21713] [PMID: 16411180]

Wentzensen, N.; Hampl, M.; Herkert, M.; Reichert, A.; Trunk, M.J.; Poremba, C.; Ridder, R.; von Knebel Doeberitz, M. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples. Cancer, 2006, 107(9), 2307-2313.
[http://dx.doi.org/10.1002/cncr.22247] [PMID: 17029280]

Shroyer, K.R.; Homer, P.; Heinz, D.; Singh, M. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology. Cancer, 2006, 108(5), 324-330.
[http://dx.doi.org/10.1002/cncr.22171] [PMID: 16937378]

Guo, M.; Baruch, A.C.; Silva, E.G.; Jan, Y.J.; Lin, E.; Sneige, N.; Deavers, M.T. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am. J. Clin. Pathol., 2011, 135(2), 212-220.
[http://dx.doi.org/10.1309/AJCP1LLX8QMDXHHO] [PMID: 21228361]

Murphy, N.; Ring, M.; Heffron, C.C.; King, B.; Killalea, A.G.; Hughes, C.; Martin, C.M.; McGuinness, E.; Sheils, O.; O’Leary, J.J. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J. Clin. Pathol., 2005, 58(5), 525-534.
[http://dx.doi.org/10.1136/jcp.2004.018895] [PMID: 15858126]

Kruse, A-J.; Baak, J.P.A.; Helliesen, T.; Kjellevold, K.H.; Bol, M.G.W.; Janssen, E.A.M. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am. J. Surg. Pathol., 2002, 26(11), 1501-1507.
[http://dx.doi.org/10.1097/00000478-200211000-00013] [PMID: 12409727]

Luttmer, R.; Dijkstra, M.G.; Snijders, P.J.; Berkhof, J.; van Kemenade, F.J.; Rozendaal, L.; Helmerhorst, T.J.; Verheijen, R.H.; Ter Harmsel, W.A.; van Baal, W.M. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population. Modern pathology: an official journal of the United States and Canadian Academy of Pathology. Inc, 2016, 29(8), 870-878.

Zacapala-Gómez, A.E.; Navarro-Tito, N.; Alarcón-Romero, L.D.C.; Ortuño-Pineda, C.; Illades-Aguiar, B.; Castañeda-Saucedo, E.; Ortiz-Ortiz, J.; Garibay-Cerdenares, O.L.; Jiménez-López, M.A.; Mendoza-Catalán, M.A. Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer. BMC Cancer, 2018, 18(1), 349.
[http://dx.doi.org/10.1186/s12885-018-4243-7] [PMID: 29587669]

Del Pino, M.; Svanholm-Barrie, C.; Torné, A.; Marimon, L.; Gaber, J.; Sagasta, A.; Persing, D.H.; Ordi, J. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer. Modern pathology: an official journal of the United States and Canadian Academy of Pathology. Inc, 2015, 28(2), 312-320.

Jafari Najaf Abadi, M.H.; Shafabakhsh, R.; Asemi, Z.; Mirzaei, H.R.; Sahebnasagh, R.; Mirzaei, H.; Hamblin, M.R. CFIm25 and alternative polyadenylation: Conflicting roles in cancer. Cancer Lett., 2019, 459, 112-121.
[http://dx.doi.org/10.1016/j.canlet.2019.114430] [PMID: 31181319]

Shabaninejad, Z.; Vafadar, A.; Movahedpour, A.; Ghasemi, Y.; Namdar, A.; Fathizadeh, H.; Pourhanifeh, M.H.; Savardashtaki, A.; Mirzaei, H. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J. Ovarian Res., 2019, 12(1), 84.
[http://dx.doi.org/10.1186/s13048-019-0558-5] [PMID: 31481095]

Shabaninejad, Z.; Yousefi, F.; Movahedpour, A.; Ghasemi, Y.; Dokanehiifard, S.; Rezaei, S.; Aryan, R.; Savardashtaki, A.; Mirzaei, H. Electrochemical-based biosensors for microRNA detection: Nanotechnology comes into view. Anal. Biochem., 2019, 581113349
[http://dx.doi.org/10.1016/j.ab.2019.113349] [PMID: 31254490]

Vafadar, A.; Shabaninejad, Z.; Movahedpour, A.; Mohammadi, S.; Fathullahzadeh, S.; Mirzaei, H.R.; Namdar, A.; Savardashtaki, A.; Mirzaei, H. Long Non-Coding RNAs As Epigenetic Regulators in Cancer. Curr. Pharm. Des., 2019, 25(33), 3563-3577.
[http://dx.doi.org/10.2174/1381612825666190830161528] [PMID: 31470781]

Jamali, Z; Taheri-Anganeh, M; Shabaninejad, Z; Keshavarzi, A; Taghizadeh, H; Razavi, ZS; Mottaghi, R; Abolhassan, M; Movahedpour, A; Mirzaei, H Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy., 2020.

Nahand, JS; Mahjoubin-Tehran, M; Moghoofei, M; Pourhanifeh, MH; Mirzaei, HR; Asemi, Z; Khatami, A; Bokharaei-Salim, F; Mirzaei, H; Hamblin, MR Exosomal miRNAs: novel players in viral infection., 2020, 12(4), 353-370.
[http://dx.doi.org/10.2217/epi-2019-0192]

Naeli, P.; Pourhanifeh, M.H.; Karimzadeh, M.R.; Shabaninejad, Z.; Movahedpour, A.; Tarrahimofrad, H.; Mirzaei, H.R.; Bafrani, H.H.; Savardashtaki, A.; Mirzaei, H.; Hamblin, M.R. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit. Rev. Oncol. Hematol., 2020, 145102854
[http://dx.doi.org/10.1016/j.critrevonc.2019.102854] [PMID: 31877535]

Sadri Nahand, J; Bokharaei-Salim, F; Karimzadeh, M; Moghoofei, M; Karampoor, S; Mirzaei, HR; Tabibzadeh, A; Jafari, A; Ghaderi, A; Asemi, Z MicroRNAs and exosomes: key players in HIV pathogenesis., 2020, 21(4), 246-278.
[http://dx.doi.org/10.1111/hiv.12822]

Savardashtaki, A; Shabaninejad, Z; Movahedpour, A; Sahebnasagh, R; Mirzaei, H; Hamblin, MR miRNAs derived from cancer-associated fibroblasts in colorectal cancer., 11(14), 1627-1645.2019,

Gholamin, S.; Mirzaei, H.; Razavi, S.M.; Hassanian, S.M.; Saadatpour, L.; Masoudifar, A.; ShahidSales, S.; Avan, A. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. J. Cell. Physiol., 2018, 233(2), 866-879.
[http://dx.doi.org/10.1002/jcp.25793] [PMID: 28145567]

Keshavarz, M.; Mirzaei, H.; Salemi, M.; Momeni, F.; Mousavi, M.J.; Sadeghalvad, M.; Arjeini, Y.; Solaymani-Mohammadi, F.; Sadri Nahand, J.; Namdari, H.; Mokhtari-Azad, T.; Rezaei, F. Influenza vaccine: Where are we and where do we go? Rev. Med. Virol., 2019, 29(1)e2014
[http://dx.doi.org/10.1002/rmv.2014] [PMID: 30408280]

Khani, P.; Nasri, F.; Khani Chamani, F.; Saeidi, F.; Sadri Nahand, J.; Tabibkhooei, A.; Mirzaei, H. Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. J. Neurochem., 2019, 148(2), 188-203.
[http://dx.doi.org/10.1111/jnc.14616] [PMID: 30347482]

Mirzaei, H.; Ferns, G.A.; Avan, A.; Mobarhan, M.G. Cytokines and MicroRNA in Coronary Artery Disease. Adv. Clin. Chem., 2017, 82, 47-70.
[http://dx.doi.org/10.1016/bs.acc.2017.06.004] [PMID: 28939213]

Pakshir, K.; Badali, H.; Nami, S.; Mirzaei, H.; Ebrahimzadeh, V.; Morovati, H. Interactions between immune response to fungal infection and microRNAs: The pioneer tuners. Mycoses, 2020, 63(1), 4-20.
[http://dx.doi.org/10.1111/myc.13017] [PMID: 31597205]

Rabieian, R.; Boshtam, M.; Zareei, M.; Kouhpayeh, S.; Masoudifar, A.; Mirzaei, H. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J. Cell. Biochem., 2018, 119(1), 17-27.
[http://dx.doi.org/10.1002/jcb.26146] [PMID: 28520219]

Saeedi Borujeni, M.J.; Esfandiary, E.; Baradaran, A.; Valiani, A.; Ghanadian, M.; Codoñer-Franch, P.; Basirat, R.; Alonso-Iglesias, E.; Mirzaei, H.; Yazdani, A. Molecular aspects of pancreatic β-cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA. J. Cell. Physiol., 2019, 234(6), 8411-8425.
[http://dx.doi.org/10.1002/jcp.27755] [PMID: 30565679]

Rezaei, S.; Mahjoubin-Tehran, M.; Aghaee-Bakhtiari, S.H.; Jalili, A.; Movahedpour, A.; Khan, H.; Moghoofei, M.; Shojaei, Z.; R Hamblin, M.; Mirzaei, H. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. Crit. Rev. Oncol. Hematol., 2020, 153103063
[http://dx.doi.org/10.1016/j.critrevonc.2020.103063] [PMID: 32712519]

Hoseini, Z.; Sepahvand, F.; Rashidi, B.; Sahebkar, A.; Masoudifar, A.; Mirzaei, H. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J. Cell. Physiol., 2018, 233(3), 2116-2132.
[http://dx.doi.org/10.1002/jcp.25930] [PMID: 28345767]

Jamali, L.; Tofigh, R.; Tutunchi, S.; Panahi, G.; Borhani, F.; Akhavan, S.; Nourmohammadi, P.; Ghaderian, S.M.H.; Rasouli, M.; Mirzaei, H. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. J. Cell. Physiol., 2018, 233(11), 8538-8550.
[http://dx.doi.org/10.1002/jcp.26850] [PMID: 29923196]

Mirzaei, H. Stroke in Women: Risk Factors and Clinical Biomarkers. J. Cell. Biochem., 2017, 118(12), 4191-4202.
[http://dx.doi.org/10.1002/jcb.26130] [PMID: 28498508]

Mirzaei, H.; Momeni, F.; Saadatpour, L.; Sahebkar, A.; Goodarzi, M.; Masoudifar, A.; Kouhpayeh, S.; Salehi, H.; Mirzaei, H.R.; Jaafari, M.R. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy. J. Cell. Physiol., 2018, 233(2), 856-865.
[http://dx.doi.org/10.1002/jcp.25787] [PMID: 28067403]

Rashidi, B.; Hoseini, Z.; Sahebkar, A.; Mirzaei, H. Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis. J. Cell. Physiol., 2017, 232(11), 2968-2976.
[http://dx.doi.org/10.1002/jcp.25738] [PMID: 27966778]

Simonian, M.; Mosallayi, M.; Mirzaei, H. Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker. J. Cancer Res. Ther., 2018, 14(2), 475.
[PMID: 29516946]

Fathullahzadeh, S.; Mirzaei, H.; Honardoost, M.A.; Sahebkar, A.; Salehi, M. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. Cancer Gene Ther., 2016, 23(10), 327-332.
[http://dx.doi.org/10.1038/cgt.2016.34] [PMID: 27659777]

Golabchi, K.; Soleimani-Jelodar, R.; Aghadoost, N.; Momeni, F.; Moridikia, A.; Nahand, J.S.; Masoudifar, A.; Razmjoo, H.; Mirzaei, H. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers. J. Cell. Physiol., 2018, 233(4), 3016-3023.
[http://dx.doi.org/10.1002/jcp.26070] [PMID: 28657205]

Javandoost, E.; Firoozi-Majd, E.; Rostamian, H.; Khakpoor-Koosheh, M.; Mirzaei, H.R. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis. Curr. Med. Chem., 2020, 27(2), 282-297.
[http://dx.doi.org/10.2174/0929867326666190911114842] [PMID: 31544709]

Masoudi, M.S.; Mehrabian, E.; Mirzaei, H. MiR-21: A key player in glioblastoma pathogenesis. J. Cell. Biochem., 2018, 119(2), 1285-1290.
[http://dx.doi.org/10.1002/jcb.26300] [PMID: 28727188]

Mirzaei, H.; Fathullahzadeh, S.; Khanmohammadi, R.; Darijani, M.; Momeni, F.; Masoudifar, A.; Goodarzi, M.; Mardanshah, O.; Stenvang, J.; Jaafari, M.R.; Mirzaei, H.R. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia. J. Cell. Physiol., 2018, 233(2), 888-900.
[http://dx.doi.org/10.1002/jcp.25799] [PMID: 28084621]

Mirzaei, H; Gholamin, S; Shahidsales, S; Sahebkar, A; Jaafari, MR; Mirzaei, HR; Hassanian, SM; Avan, A MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma., European journal of cancer (Oxford, England : 1990), 2016, 53, 25-32.
[http://dx.doi.org/10.1016/j.ejca.2015.10.009]

Mirzaei, H.; Khataminfar, S.; Mohammadparast, S.; Sales, S.S.; Maftouh, M.; Mohammadi, M.; Simonian, M.; Parizadeh, S.M.; Hassanian, S.M.; Avan, A. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. Curr. Med. Chem., 2016, 23(36), 4135-4150.
[http://dx.doi.org/10.2174/0929867323666160818093854] [PMID: 27538692]

Mirzaei, H.; Masoudifar, A.; Sahebkar, A.; Zare, N.; Sadri Nahand, J.; Rashidi, B.; Mehrabian, E.; Mohammadi, M.; Mirzaei, H.R.; Jaafari, M.R. MicroRNA: A novel target of curcumin in cancer therapy. J. Cell. Physiol., 2018, 233(4), 3004-3015.
[http://dx.doi.org/10.1002/jcp.26055] [PMID: 28617957]

Mirzaei, H.R.; Sahebkar, A.; Mohammadi, M.; Yari, R.; Salehi, H.; Jafari, M.H.; Namdar, A.; Khabazian, E.; Jaafari, M.R.; Mirzaei, H. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. Curr. Pharm. Des., 2016, 22(34), 5257-5269.
[http://dx.doi.org/10.2174/1381612822666160303110838] [PMID: 26935703]

Mohammadi, M.; Goodarzi, M.; Jaafari, M.R.; Mirzaei, H.R.; Mirzaei, H. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Ther., 2016, 23(11), 371-372.
[http://dx.doi.org/10.1038/cgt.2016.45] [PMID: 27740613]

Moridikia, A.; Mirzaei, H.; Sahebkar, A.; Salimian, J. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J. Cell. Physiol., 2018, 233(2), 901-913.
[http://dx.doi.org/10.1002/jcp.25801] [PMID: 28092102]

Naeli, P.; Yousefi, F.; Ghasemi, Y.; Savardashtaki, A.; Mirzaei, H. The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy. Curr. Mol. Med., 2020, 20(2), 90-101.
[http://dx.doi.org/10.2174/1566524019666191001113511] [PMID: 31573883]

Shen, S.N.; Wang, L.F.; Jia, Y.F.; Hao, Y.Q.; Zhang, L.; Wang, H. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn. Pathol., 2013, 8, 69.
[http://dx.doi.org/10.1186/1746-1596-8-69] [PMID: 23631806]

Wang, X.; Tang, S.; Le, S.Y.; Lu, R.; Rader, J.S.; Meyers, C.; Zheng, Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 2008, 3(7)e2557
[http://dx.doi.org/10.1371/journal.pone.0002557] [PMID: 18596939]

Xu, J.; Li, Y.; Wang, F.; Wang, X.; Cheng, B.; Ye, F.; Xie, X.; Zhou, C.; Lu, W. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene, 2013, 32(8), 976-987.
[http://dx.doi.org/10.1038/onc.2012.121] [PMID: 22469983]

Li, C.; Zheng, X.; Li, W.; Bai, F.; Lyu, J.; Meng, Q.H. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. BMC Cancer, 2018, 18(1), 61.
[http://dx.doi.org/10.1186/s12885-017-3753-z] [PMID: 29316891]

Guo, H.; Yang, S.; Xu, L.; Li, D.; Tang, J.; Wang, S.; Wei, B.; Liu, Z. Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population. Oncol. Lett., 2016, 12(1), 721-726.
[http://dx.doi.org/10.3892/ol.2016.4655] [PMID: 27347206]

Wang, S.; Wu, S.; Zhu, H.; Ding, B.; Cai, Y.; Ni, J.; Wu, Q.; Meng, Q.; Zhang, X.; Zhang, C.; Li, X.; Wang, M.; Chen, R.; Jin, H.; Zhang, Z. PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population. Sci. Rep., 2016, 6, 23465.
[http://dx.doi.org/10.1038/srep23465] [PMID: 27001215]

Zidi, S.; Stayoussef, M.; Alsaleh, B.L.; Gazouani, E.; Mezlini, A.; Ebrahim, B.H.; Yacoubi-Loueslati, B.; Almawi, W.Y. Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study. Pathol. Oncol. Res., 2017, 23(2), 385-392.
[http://dx.doi.org/10.1007/s12253-016-0127-9] [PMID: 27722983]

Lutkowska, A.; Roszak, A.; Lianeri, M.; Sowińska, A.; Sotiri, E.; Jagodziński, P.P. Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression. Mol. Diagn. Ther., 2017, 21(2), 199-207.
[http://dx.doi.org/10.1007/s40291-017-0256-1] [PMID: 28120299]

Gong, J.M.; Shen, Y.; Shan, W.W.; He, Y.X. The association between MTHFR polymorphism and cervical cancer. Sci. Rep., 2018, 8(1), 7244.
[http://dx.doi.org/10.1038/s41598-018-25726-9] [PMID: 29740106]

Li, L.; Liu, J.; Liu, C.; Lu, X. The correlation between TNF-α-308 gene polymorphism and susceptibility to cervical cancer. Oncol. Lett., 2018, 15(5), 7163-7167.
[http://dx.doi.org/10.3892/ol.2018.8246] [PMID: 29725439]

Campitelli, M.; Jeannot, E.; Peter, M.; Lappartient, E.; Saada, S.; de la Rochefordière, A.; Fourchotte, V.; Alran, S.; Petrow, P.; Cottu, P.; Pierga, J.Y.; Lantz, O.; Couturier, J.; Sastre-Garau, X. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One, 2012, 7(8)e43393
[http://dx.doi.org/10.1371/journal.pone.0043393] [PMID: 22937045]

Takakura, M.; Matsumoto, T.; Nakamura, M.; Mizumoto, Y.; Myojyo, S.; Yamazaki, R.; Iwadare, J.; Bono, Y.; Orisaka, S.; Obata, T.; Iizuka, T.; Kagami, K.; Nakayama, K.; Hayakawa, H.; Sakurai, F.; Mizuguchi, H.; Urata, Y.; Fujiwara, T.; Kyo, S.; Sasagawa, T.; Fujiwara, H. Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells. Cancer Sci., 2018, 109(1), 231-240.
[http://dx.doi.org/10.1111/cas.13449] [PMID: 29151279]

Wen, Y.F.; Cheng, T.T.; Chen, X.L.; Huang, W.J.; Peng, H.H.; Zhou, T.C.; Lin, X.D.; Zeng, L.S. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy. PLoS One, 2018, 13(10)e0204334
[http://dx.doi.org/10.1371/journal.pone.0204334] [PMID: 30303986]

Su, Y.F.; Wu, T.F.; Ko, J.L.; Tsai, H.T.; Tee, Y.T.; Chien, M.H.; Chou, C.H.; Lin, W.L.; Low, H.Y.; Chou, M.Y.; Yang, S.F.; Wang, P.H. The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients. PLoS One, 2014, 9(3)e91644
[http://dx.doi.org/10.1371/journal.pone.0091644] [PMID: 24637958]

Zhou, X; Xu, CJ; Wang, JX; Dai, T; Ye, YP; Cui, YM; Liao, WT; Wu, XL; Ou, JP Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer., International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, 25(8), 1353-1363.
[http://dx.doi.org/10.1097/IGC.0000000000000524]

Wang, H.R.; Li, Y.C.; Guo, H.Q.; Yu, L.L.; Wu, Z.; Yin, J.; Liao, G.D.; Qu, Y.M.; Jiang, Y.; Wang, D.; Chen, W. A cocktail of p16^INK4a and Ki-67, p16^INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening. Oncotarget, 2017, 8(48), 83890-83899.
[http://dx.doi.org/10.18632/oncotarget.19870] [PMID: 29137390]

Shi, W.J.; Liu, H.; Wu, D.; Tang, Z.H.; Shen, Y.C.; Guo, L. E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population. Oncol. Lett., 2017, 14(5), 6251-6258.
[http://dx.doi.org/10.3892/ol.2017.6932] [PMID: 29113275]

Zhu, L.; Zheng, X.; Du, Y.; Xing, Y.; Xu, K.; Cui, L. Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer. OncoTargets Ther., 2018, 11, 4207-4220.
[http://dx.doi.org/10.2147/OTT.S160998] [PMID: 30050312]

Barrón, E.V.; Roman-Bassaure, E.; Sánchez-Sandoval, A.L.; Espinosa, A.M.; Guardado-Estrada, M.; Medina, I.; Juárez, E.; Alfaro, A.; Bermúdez, M.; Zamora, R.; García-Ruiz, C.; Gomora, J.C.; Kofman, S.; Pérez-Armendariz, E.M.; Berumen, J. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer. PLoS One, 2015, 10(9)e0137397
[http://dx.doi.org/10.1371/journal.pone.0137397] [PMID: 26372210]

Dürst, M.; Hoyer, H.; Altgassen, C.; Greinke, C.; Häfner, N.; Fishta, A.; Gajda, M.; Mahnert, U.; Hillemanns, P.; Dimpfl, T.; Lenhard, M.; Petry, K.U.; Runnebaum, I.B.; Schneider, A. Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status. Oncotarget, 2015, 6(26), 23015-23025.
[http://dx.doi.org/10.18632/oncotarget.4132] [PMID: 26008982]

Sørbye, S.W.; Fismen, S.; Gutteberg, T.J.; Mortensen, E.S.; Skjeldestad, F.E. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study. BMJ Open, 2016, 6(8)e011981
[http://dx.doi.org/10.1136/bmjopen-2016-011981] [PMID: 27515759]

Ma, Q.; Wan, G.; Wang, S.; Yang, W.; Zhang, J.; Yao, X. Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell Int., 2014, 14, 81.
[http://dx.doi.org/10.1186/s12935-014-0081-0] [PMID: 25788864]

Luo, M.; Shen, D.; Wang, W.; Xian, J. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Int. J. Clin. Exp. Pathol., 2015, 8(5), 5542-5548.
[PMID: 26191262]

Liu, P.; Xin, F.; Ma, C.F. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer. Genet. Mol. Res., 2015, 14(4), 17995-18002.
[http://dx.doi.org/10.4238/2015.December.22.25] [PMID: 26782446]

Sun, L.; Jiang, R.; Li, J.; Wang, B.; Ma, C.; Lv, Y.; Mu, N. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Ann. Clin. Biochem., 2017, 54(1), 127-133.
[http://dx.doi.org/10.1177/0004563216649377] [PMID: 27166306]

Park, S.; Eom, K.; Kim, J.; Bang, H.; Wang, H.Y.; Ahn, S.; Kim, G.; Jang, H.; Kim, S.; Lee, D.; Park, K.H.; Lee, H. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer, 2017, 17(1), 658.
[http://dx.doi.org/10.1186/s12885-017-3642-5] [PMID: 28934937]

Li, M.; Li, B.Y.; Xia, H.; Jiang, L.L. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. Eur. Rev. Med. Pharmacol. Sci., 2017, 21(10), 2346-2350.
[PMID: 28617557]

Nagamitsu, Y.; Nishi, H.; Sasaki, T.; Takaesu, Y.; Terauchi, F.; Isaka, K. Profiling analysis of circulating microRNA expression in cervical cancer. Mol. Clin. Oncol., 2016, 5(1), 189-194.
[http://dx.doi.org/10.3892/mco.2016.875] [PMID: 27330796]

Xin, F.; Liu, P.; Ma, C.F. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. Eur. Rev. Med. Pharmacol. Sci., 2016, 20(23), 4846-4851.
[PMID: 27981553]

Carow, K.; Gölitz, M.; Wolf, M.; Häfner, N.; Jansen, L.; Hoyer, H.; Schwarz, E.; Runnebaum, I.B.; Dürst, M. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA. Int. J. Mol. Sci., 2017, 18(10)E2032
[http://dx.doi.org/10.3390/ijms18102032] [PMID: 28937589]